Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension

Table 1

Main clinical and laboratory features of the present study population.

	Total (𝑛=60)	Metoprolol (𝑛=30)	Nebivolol (𝑛=30)	𝑃 value
Age	54.3±10.7	55.7±11.7	52.8±9.5	0.3
Female (𝑛, %)	13 (21.6)	7 (23.3)	6 (20)	0.51
Smoking (𝑛, %)	17 (28.3)	8 (26.6)	9 (30)	0.5
Family history (𝑛, %)	10 (16.6)	5 (16.6)	5 (16.6)	0.6
Hyperlipidemia (𝑛, %)	14 (23.3)	6 (20)	8 (26.6)	0.38
Body mass index (kg/m^2)	27.5±3.4	27.6±3.2	27.2±3.7	0.62
Creatinine (mg/dL)	0.77±0.14	0.79±0.13	0.74±0.15	0.2
Glucose (mg/dL)	94.7±13.6	95.5±14.7	93.9±12.8	0.66
Hemoglobin (gm/dL)	13.6±1.3	13.7±1.3	13.6±1.3	0.92
Left ventricle ejection fraction (%)	69±4.2	68.8±3.8	69.1±4.7	0.79
E/A ratio	0.93±0.32	0.92±0.28	0.93±0.34	0.91
Left ventricle mass index	107.7±18.1	108.1±12.2	107.2±22.8	0.86